The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.
Letter to the editor
Editor, Writing as a patient, I wish to point out that in Dr J. Turnidge's editorial on antibiotics ('What to use instead of flucloxacillin' Aust Prescr 1995;18:54-6), he seems to approve of chloramphenicol drops and ointment for the eyes when he refers to its 'popular topical use'.
In another editorial1, the authors warn that chloramphenicol can suppress the bone marrow even when it is applied externally to the eyes. They recommend that it not be used unless there be no alternative and they suggest 'framycetin and fusidic acid are but two of many safer and equally effective preparations'.
John P. O'Brien
- Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? Br Med J 1995;310:1217-8.